Gold seed fiducial markers for prostate radiation therapy: Describing prostate motiondoi:10.1002/j.2051-3909.2011.tb00152.xgold seed fiducial markerprostate localisationimagingPurpose : Gold seed fiducial markers can be used to accurately define daily treatment field placement for prostate cancer patients....
Removal of the prostate gland often eradicates early-stage cancer. But patients whose cancer has spread may need to follow up with what is known as salvage radiation therapy. Researchers at Fox Chase have now determined a better way to monitor outcomes after this procedure. A team led by Mark...
in terms of identifying the men for these studies who are at high risk for early death due to ineffective initial treatment for their prostate cancer," stated Anthony Victor D'Amico, MD, PhD, chief, Genitourinary Radiation Oncology, Brigham and Women's Hospital and senior author of the study...
Dosimetric Impact and Theoretical Clinical Benefits of Fiducial Markers for Dose Escalated Prostate Cancer Radiation Treatment To assess the impact of fiducial markers and daily kilovoltage imaging (FM-kV) on dose–volume histogram (DVH) parameters and normal tissue complication pr... I Gauthier,JF ...
metabolic by-products, exogenous agents or extrinsic sources such as ultraviolet light or ionizing radiation. The checkpoint delays cell-cycle progression to allow the cell time for repair of the damaged DNA. The G2 DNA damage checkpoint arrests cells in G2 phase, stopping the cells from entering...
In 1936 prostatic acid phosphatase (PAP) became the key serum marker for monitoring prostate cancer (PCa) treatment (1–3). Approximately 50 yr later, prostate-specific antigen (PSA) emerged as the most useful serum marker for PCa management followed a f
(2009) Effectiveness of Using Fewer Implanted Fiducial Markers for Prostate Target Alignment . International Journal of Radiation Oncology Biology Physics 74 : 1283–1289.Kudchadker PJ, Lee AK, Yu ZH et al. Effectiveness of using fewer implanted fiducial markers for prostate target alignment. Int ...
Prognostic and Predictive Markers for Immunotherapy in Non Small Cell Lung Cancer n the last decade, lung cancer patients have benefited from novel and efficient therapies such as immunotherapy. However, currently, there is no standardiz... PV Filip,M Farcas - 《Journal of Medical & Radiation On...
The molecular definition of significant and lethal prostate cancer is still a highly relevant issue, that has no definitive answer yet. The even more refined demand for biomarkers that specifically predict the long-term outcome of surgery vs radiation therapy will prob- ably not be satisfied in ...
1996). During radiation therapy, plasma levels in those patients with elevations declined, and at last follow-up, the TGF-β1 levels correlated significantly with disease status (3 of 4 patients with no evidence of cancer had normal levels compared with 2 of 16 patients with residual or ...